EPHA2 and gastric cancer: EPHA2 is reported to be overexpressed in gastric cancer (Hong et al., 2018) and colorectal cancer (Hong et al., 2018) and is involved in the increased invasion, migration, and prognosis of colorectal cancer cells (Hong et al., 2018).